Parkin Exon Rearrangements and Sequence Variants in LRRK2 Mutations Carriers: Analysis on a Possible Modifier Effect on LRRK2 Penetrance

Table 1

Oligonucleotides used for the ASOs technique. The nucleotide change in the oligonucleotides is underlined.

Exon 31	1441 wild-type allele R	5^′-CCCTCCAGGCTCGCGCTTC- 3^′
	1441 mutant allele C	5^′-CCCTCCAGGCTTGCGCTTC- 3^′
	1441 mutant allele G	5^′-CCCTCCAGGCTGGCGCTTC- 3^′
	1441 mutant allele H	5^′-CCCTCCAGGCTCACGCTTC- 3^′
Exon 41	2019 wild-type allele G	5^′-AAAGATTGCTGACTACGGCA-3
	2019 mutant allele S	5^′-AAAGATTGCTGACTACAGCA- 3^′
	2020 wild-type allele I	5^′-GCATTGCTCAGTACTGCTGT- 3^′
	2020 mutant allele T	5^′-GCACTGCTCAGTACTGCTGT- 3^′